HEALTH EDUCATION THAMES VALLEY: ACADEMIC
CLINICAL FELLOWSHIP IN HISTOPATHOLOGY
Academic Clinical Fellowship (ACF) posts are awarded by the NIHR to
University/NHS Trust/Deanery partnerships nationally through a formula mechanism
and by competition. These posts form part of the NIHR Integrated Training Pathway,
further details of which can be found on the NIHR TCC website
http://www.nihrtcc.nhs.uk
Please note: for 2016, in addition to the academic interviews, candidates will be
required to attend and pass a clinical interview for the specialty they are applying to
for academic training, if appropriate. Offers made will therefore be conditional upon
meeting the required standard in the clinical interview. Please check the FAQs
(http://www.oxforddeanery.nhs.uk/pdf/2015 Applicant NIHR ACF FAQs.pdf) on the
HETV website for more information.
About Health Education Thames Valley
We are the Local Education and Training Board (LETB) for Thames Valley covering
Berkshire, Buckinghamshire and Oxfordshire. Our vision is to ensure the delivery of
effective workforce planning and excellent education and training to develop a highly
capable, flexible and motivated workforce that delivers improvements in health for
the population of Thames Valley. Thames Valley LETB is responsible for the training
of around 2000 Foundation and Specialty trainees.
Health Education Thames Valley (HETV) is a relatively small organisation with a
defined geographical area which serves as a single unit of application. In the majority
of cases successful candidates will be asked to preference their choice of location
for either one or two years. Some programmes will require successful candidates to
indicate a location and specialty. Future placements will usually be based on
individual training and educational needs. Please note that applications are to the
Health Education Thames Valley as a whole. This may mean that you may be
allocated to any geographic location within the deanery depending on training
needs.
About Research in Oxford
Oxford University Hospitals NHS Trust and Oxford University, in partnership have an
international reputation for research excellence. Patients benefit from world-class
discovery and innovation and a growing portfolio of studies addressing major
conditions including cancer, dementia and stroke. Oxford is a National Institute for
Health Research Biomedical Research Centre, an Experimental Cancer Medicine
Centre and a CRUK Major Cancer Centre. Oxford University Hospitals NHS Trust is
the host NHS Trust for the Oxford Academic Health Science Network – one of 15
AHSNs across England and an Academic Health Science Centre. Opportunities for
research are extensive and often involve novel collaborations with research groups
outside of medicine e.g. with engineers.
Oxford has been recently designated as one of 11 Genomic Medicine Centres as
part of the 100,000 Genomes Project main programme. This provides numerous
opportunities for working with whole genome sequence data in both diagnostics and
research. Oxford University Hospitals is home to the Oxford Molecular Diagnostics
Centre (MDC), headed by Professor Anna Schuh and which is a fully CPAaccredited NHS laboratory that comprises the Oxford Regional Genetics Laboratory
(ORGL), the Molecular Pathology and Haematology Laboratory, a clinical Next
Generation Sequencing (NGS) core facility and the Oxford GEL BioRepository.
Heads of Bioinformatics and Clinical Informatics are responsible for the analysis of
NGS data and aggregation of phenotypic data, respectively. The MDC receives
referrals from NHS, industry, clinical trials and research groups. It comprises a BRC
funded R&D unit to develop, innovate, validate and evaluate clinical utility of
genomics.
The NHS Cellular Pathology department at the John Radcliffe Hospital, Oxford has
close links with several university departments, including the Nuffield Department of
Clinical Laboratory Sciences, headed by Professor Alison Banham and the Nuffield
Department of Surgical Sciences, headed by Professor Freddie Hamdy. Several of
the consultants within the department have established proven track records in
research with several grants and numerous publications in high impact international
journals.
A key area for development within Cellular Pathology is digital pathology and image
analysis, both on a diagnostics and research front. Digital pathology academic and
working groups have been recently formed to drive this area forward and is likely to
be a vibrant area of research activity over the next couple of years. Novel
collaborations have been formed, including with bioengineers such as Professor
Jens Rittscher at the Target Discovery Institute, University of Oxford.
Description of the Post
This is a post for up to 3 years duration. Approximately 2 of the 3 years will be spent
in Oxford and the remainder in the regional DGH's. The post is for histopathology
trainees who will be starting in year 2 or 3 of their training at the time of
commencement of the post (ST2 or ST3).
This is a 75% clinical post with a 25% academic component. It is envisaged that this
will be as a 3 month research block and 9 months clinical per year, however this is
flexible and can be configured differently in the interests of the project and the
appointee.
Several consultant pathologists within Cellular Pathology have academically funded
time via their own research funding, the BRC or the CRUK Cancer Centre. Dr Clare
Verrill leads the BRC funded team of pathologists. These pathologists are supporting
large numbers of clinical trials, research projects and the 100,000 Genomes Project.
Having academically minded pathologists, will enable the ACF to be mentored and
supported in embarking on research projects.
It is envisaged that the ACF will embark on a molecular pathology project
encompassing whole genome sequencing or a project employing elements of digital
pathology and molecular pathology within their 9 months of research time. The ACF
will have the opportunity to (at least in part) influence their area of study within
molecular diagnostics. The project can focus on any tumour area, but areas of strong
research interest currently include urological pathology, haematopathology or GI
pathology (among others) or the project may involve more generic whole genome
sequencing issues and cross tumour site boundaries involving multiple sites of
interest. The research areas of molecular diagnostics and digital pathology have
been chosen in order to equip the ACF with the necessary skills to function at
consultant level integrating molecular diagnostics and digital pathology into their
everyday work (skills which are essential for the future of histopathology).
The ACF will have an academic supervisor and an educational supervisor. The
academic supervisor will act as a mentor. The ultimate aim of the post is to enable
the appointee to develop a project in order to apply for external funding to undertake
a DPhil/PhD. In the event that funding is not secured the appointee will return to fulltime clinical training.
This post attracts an NTN(a).
The Histopathology Training Programme in HETV - General Information
The School of Histopathology in HETV is a popular school with training being well
balanced between the District General Hospitals within the Thames Valley Region
and the John Radcliffe Hospital in Oxford.
The region has a Histopathology Training School for the ST1s (Specialty Trainee
year 1) which is based at Wycombe Hospital, although this School is integrated with
the rest of the School of Histopathology in region. The specialty trainees in year 2
and above are based at Wycombe Hospital (High Wycombe), Wexham Park Hospital
(Slough), the Royal Berkshire Hospital (Reading) and the John Radcliffe Hospital
(Oxford). Generally those in years 2 and 3 of training who are not in an academic
post are based in the District General Hospitals, before rotating to the John Radcliffe
Hospital in year 4. The provision of cervical cytopathology training for those in
Wexham Park Hospital and the Royal Berkshire Hospital is at the John Radcliffe
Hospital and as such trainees on placement in either of these hospitals will be
required to travel to the John Radcliffe Hospital for this component of their training.
Similarly, training in diagnostic neuropathology and paediatric pathology in ST1 or
ST2 will take place at the John Radcliffe Hospital. There is provision of training in
soft tissue and bone pathology at the Nuffield Orthopaedic Centre which is part of
OUH NHS Trust.
Rotations may at times change in response to clinical need from the Trusts and in
accordance with training needs of the individual.
For the purpose of this ACF post, it is anticipated that approximately 2 of the 3 years
will be spent in Oxford and the remainder of the time in the regional District General
Hospitals. As such, the post-holder may find themselves employed by any of the
following Trusts and placed in any of the following hospitals:
Trust
Buckinghamshire
Healthcare NHS Trust
Hospitals and Locations
Wycombe Hospital, High Wycombe
http://www.buckshealthcare.nhs.uk/
Royal
Berkshire
Foundation Trust
NHS Royal Berkshire Hospital, Reading
http://www.royalberkshire.nhs.uk/
Frimley
Health
Foundation Trust
NHS Wexham Park Hospital, Slough
http://www.heatherwoodandwexham.nhs.uk/
Oxford University Hospitals John Radcliffe Hospital, Oxford
NHS Trust
http://www.ouh.nhs.uk/
Buckinghamshire Healthcare NHS Trust
Buckinghamshire Healthcare NHS Trust is a major provider of community and
hospital services in South Central England, providing care to over half a million
patients from Buckinghamshire and neighbouring counties every year.
Wycombe Hospital
The Cellular Pathology Department is based at Wycombe Hospital. Wycombe
Hospital is situated in the centre of the historic town of High Wycombe, and offers a
wide range of surgical services, as well as 24 hour emergency medical care
(including minor injuries) and specialist medical care, including stroke and heart
conditions. The hospital also offers specialist cancer and urological services.
With some of the lowest waiting times for surgery nationally, the hospital is the area’s
major hub for planned surgical care. Our top class teams carry out over 24,900
operations every year. Wycombe Hospital sees more than 36,000 inpatients and
145,000 outpatients a year and the emergency medical centre sees more than
44,000 patients.
Wycombe is also home to a newly-refurbished midwifery-led maternity unit aimed at
providing a more home-from-home environment for women and their partners. This
provides women with a wider choice on style of care, and complements our full
consultant-led
maternity
service
at
Stoke
Mandeville.
Cellular Pathology at Wycombe Hospital
Buckinghamshire Healthcare NHS Trust comprises 3 hospitals; Stoke Mandeville
Hospital, Wycombe Hospital and Amersham Hospital. Cellular Pathology services in
the Trust merged on the Wycombe Hospital site in April 2012. Wycombe Hospital is
the site of most elective surgery in the Trust. The Breast Team within the Trust is
merged on the Wycombe site. Intra-operative molecular diagnosis of lymph node
metastases (OSNA) was introduced 5 years ago. The OSNA analyser is located in
the Histology laboratory.
Buckinghamshire Healthcare hosts the Oxford Deanery (ST1) Cellular Pathology
Training School.
Departmental Workloads:
Autopsies:
The post mortem workload averages approximately 800 per year between the two
Mortuaries (mainly for H.M. Coroner).
Cytopathology:
Cellular Pathology receives more than 4,000 non-gynaecological cytology specimens
including FNAs from a variety of sites. The department also receives about 65,000
gynaecological cytology specimens per year and provides the Cervical Screening
services for Aylesbury, High Wycombe and Milton Keynes.
Surgical Pathology:
Cellular Pathology receives approximately 28,000 histopathology specimens per
year.
Breast pathology (including breast screening) is well represented, as are
gynaecological, urological and gastro-intestinal pathology and dermatopathology.
The Regional plastic surgery unit is based at Stoke Mandeville Hospital and this
department provides a wealth of skin and soft tissue pathology. We also receive
skin biopsies from dermatology and general practice, GI, bronchial biopsies and
prostatic core biopsies. There is an active Haematology and Oncology unit and
biopsies of lymphoma and other tumour pathology are received. A small amount of
ophthalmic pathology is generated by the active Ophthalmology Department and one
of the Consultants has a special interest in this field.
Frimley Health NHS Foundation Trust
Frimley Health NHS Foundation Trust provides NHS hospital services for 900,000
people across Berkshire, Hampshire, Surrey and South Buckinghamshire.
Frimley Health came into being on the 1st October 2014, following the successful
amalgamation of two neighbouring NHS trusts. Services are provided by three main
hospital sites, Frimley Park, near Camberley, Heatherwood, at Ascot and Wexham
Park in Slough along with a number of satellite centres.
Heatherwood and Wexham Park Hospital
Heatherwood & Wexham Park Hospitals NHS Foundation Trust (the Trust) is a
district general hospital that serves a population of more than 450,000 people from
the areas of Ascot, Bracknell, Maidenhead, Slough, Windsor and south
Buckinghamshire. The Trust has achieved and maintained a Top 40 rating with
CHKS for the last seven years.
The Trust employs approximately 3640 permanent staff who deliver a wide range of
quality healthcare services from two main sites, Heatherwood Hospital in Ascot
opened in the 1923, and Wexham Park Hospital in Slough opened in 1968. The
Trust also provides outpatient clinics, a breast screening and diagnostic service, a
chest clinic and other diagnostic tests at King Edward VII Hospital in Windsor,
outpatient services and diagnostic tests at St Mark’s Hospital in Maidenhead, and
outpatient services at Chalfonts and Gerrards Cross Hospital, and Fitzwilliam House
in Bracknell.
Heatherwood & Wexham Park Hospitals became a foundation trust in June 2007.
As a foundation trust it is accountable to its local community and aims to have
representative membership of its catchment area, with members providing feedback
to the Trust on the services that it provides.
Wexham Park Hospital in Slough has approximately 445 beds - General and Acute
(excluding Day Surgery beds) with a full range of services including general
medicine and its sub-specialties, paediatrics, general surgery, GIT and skin,
urology, orthopaedics, obstetrics and gynaecology, otolaryngology, oral and maxillofacial surgery and a sub-regional plastic surgery unit which has an extensive
catchment area.
In the theatre complex there are 9 new theatres and two obstetric theatres. There is
a large Accident & Emergency department, a 12 bedded combined Critical ITU/HDU,
a 15 bed Day Surgery Unit and 16 bed Short Stay Unit. There is also an 8 bedded
Coronary Care Unit, with 6 PCCU (Post Coronary Care Unit) beds and an
angiography suite. There is also an excellent rehabilitation department, a centralised
laboratory, and diagnostic imaging including a new spiral CT scanner and the MRI
scanner suite on the site.
Heatherwood Hospital in Ascot has approximately 62 beds and 11 surgical trolleys,
mainly for elective surgery for orthopaedics, general surgery, urology,
otolaryngology, plastic surgery and gynaecology. There are 6 theatres including a
Day Unit. There is also a minor injuries unit (seeing 15,000 patients in 2010/11 and
21,000 patients in 2011/12) and a diagnostic imaging unit including MRI and a CT
scanner. Physiotherapy and rehabilitation are also on site.
Histopathology and Cytopathology at Wexham Park Hospital
The department provides a diagnostic service for Heatherwood and Wexham Park
Hospital Trust and 2 PCTs. The annual workload consists of 2,943 nongynaecological specimens including FNA, 20,790 NHS surgical specimens and 439
hospital and Coroner's post-mortems (the majority being Coroner’s cases).
The department provides a diagnostic service for a wide range of specialities
including gastro-intestinal and colorectal, respiratory, gynaecology including
colposcopy together with liver, urology, breast and other surgical material. There is
no cardiothoracic or neurosurgical material.
The Cytology laboratory provides a wide range of diagnostic services including
respiratory, urology, fluid and FNA cytology.
Oxford University Hospitals NHS Trust
The Oxford University Hospitals NHS Trust (OUH) is one of the largest NHS
teaching trusts in the UK with a national and international reputation for the
excellence of its services and its role in teaching and research. Clinical care is
delivered by experienced specialists . Our trust is made up of four hospitals - the
John Radcliffe Hospital (which also includes the Children's Hospital and West Wing),
Churchill Hospital and the Nuffield Orthopaedic Centre, all located in Oxford and the
Horton General Hospital in Banbury.
The Oxford University Hospitals NHS Trust was formally established on 1 November
2011 when the Nuffield Orthopaedic Centre NHS Trust merged with the Oxford
Radcliffe Hospitals NHS Trust and became the seventh clinical division of the new
expanded organisation.
On the same date a formal Joint Working Agreement between the Trust and the
University of Oxford came into effect. This agreement builds on existing working
relationships between the two organisations (see Research section below).
The Trust provides a wide range of clinical services, including both local and
specialist services (including cardiac, cancer, musculoskeletal and neurological
rehabilitation, and specialist children’s and neonatal services) as well as medical
education, training and research.
The Trust employed over 11,500 people at the end of the financial year (2013/2014)
and had a turnover of £868 million. The Trust provides general hospital services for
people in Oxfordshire and neighbouring counties, and specialist services on a
regional and national basis.
At the Trust in 2013/14 there were:
 1 million patient contacts;
 108,000 planned admissions;
 90,000 emergency admissions;
 130,000 emergency department attendances;
 1.4 million meals for patients
 8,315 babies delivered.

The Trust’s hospitals in Oxford serve an Oxfordshire population of 655,000 and the
Horton General Hospital in Banbury has a catchment population of around 150,000
people in north Oxfordshire and neighbouring communities in south
Northamptonshire and south east Warwickshire.
Oxfordshire Clinical Commissioning Group provides 37.6% of the Trust’s income for
the delivery of patient services and 14.7% comes from other commissioners outside
Oxfordshire, notably Buckinghamshire CCGs (Aylesbury Vale and Chiltern),
Northamptonshire CCGs (Nene and Corby).
The largest commissioner of the Trust’s services is NHS England’s Wessex Area
Team who commission specialist services on behalf of our local population and also
for a regional (and in some cases national) patient group. They are responsible for
47.7% of income for services.
We have strong partnerships with the local NHS and social care organisations and
also with a wider network of district general hospitals, universities and research
institutions. Our role as a university teaching centre with a focus on research and
innovation is a defining feature and as such attracts patients from beyond our
surrounding counties.
We also engage on health issues with patients groups, our Foundation Trust
membership, local Healthwatch, the Community Partnership Network (a body hosted
by Cherwell District Council that we helped found in order to have a public forum in
which to discuss health issues in the north of the county), local authorities and the
Oxfordshire Joint Health Overview and Scrutiny Committee and Health and
Wellbeing Board.
Cellular Pathology at OUH NHS Trust
Cellular Pathology services within Oxford are provided mainly by the Cellular
Pathology Clinical Unit at the John Radcliffe Hospital. The unit has full CPA
approval. The Osteoarticular pathology unit is based at the Nuffield Orthopaedic
Centre, and is a part of the Cellular Pathology Department with its own accreditation.
During 2014 there were approximately 52,000 requests processed in the main
department for Histopathology (12% originating from primary care), 5,000 diagnostic
cytology requests, and 1000 autopsies, of which more than 95% were Coroner's
cases. Cervical screening cytology is undertaken using liquid based cytology and
HPV testing. Approximately 47,000 cases are screened per year. Autopsies are
dealt with by a few consultants on a daily rotational basis without subspecialisation.
A full and comprehensive diagnostic service is provided including routine, urgent and
same day reporting, frozen section and fine needle aspiration and other cytology
services, an extensive range of immunofluorescent and immunocytochemical
protocols, in situ hybridisation, electron microscopy and photographic services.
Molecular testing is provided in coordination with other laboratories within the
directorate. The department deals with specimens from local general practitioners,
OUH hospitals, district hospitals, and national and international referrals.
The Clinical Unit provides a fully sub-specialised service. The specialities provided in
the main department are Dermatopathology. Gastroenterological, Hepatobiliary,
Gynaecological. Breast, Endocrine, Haematopathology. Urological, Renal,
Respiratory, Head and Neck, and Paediatric Pathology. An FNA service, including
outpatient clinics supports these services, in particular Thyroid, Head and Neck and
Haematopathology. Osteoarticular Pathology is based at the Nuffield Orthopaedic
Centre. Neuropathology including Ophthalmic Pathology is based in a separate
department in the Neurosciences building of the John Radcliffe.
The main unit houses a "cut-up" room with modern equipment which allows four
simultaneous "cut-ups" to take place. In the laboratory, there are up to date staining
machines and cover-slippers and automated immunostainers. Transmission and
confocal electron microscopy are available. The mortuary is relatively new and
possesses up to date items of equipment. There is a fully equipped seminar room for
MDT meetings. This seminar room has been upgraded for video-conferencing
across the Thames Valley Cancer Network.
Research projects and teaching are supported. There is an in-house medical
illustration facility as well as a comprehensive (over 100 antibodies)
immunohistochemistry section of the laboratory. In addition, there are links to the
research laboratories on site which include Cancer Research UK and the Institute of
Molecular Medicine.
Computerisation of the service is in accord with the Trust's Information Service
policies and includes reporting and other facilities with computers available to each
Consultant. There are comprehensive e-mail facilities, electronic scheduling, and
internet access.
The NOC Histopathology Department dealt with 4546 cases in 2014. The case load
comprises a wide range of general orthopaedic pathology and includes a significant
number (approximately 1300 cases) of bone/soft tissue tumours and tumour-like
lesions. The diagnostic service is regularly called upon to provide a frozen section
histopathology and synovial fluid cytology diagnostic service. The unit has its own
on-site lead but is managerially within the Cellular Pathology department of OUH
NHS Trust.
Royal Berkshire NHS Foundation Trust
The Royal Berkshire NHS Foundation Trust achieved Foundation hospital status in June
2006. We were the first Foundation Trust in our region. We are one of Reading's biggest
employers and one of the largest general hospital foundation trusts in the country. The
Trust provides acute medical and surgical services to Reading, Wokingham and West
Berkshire and specialist services such as cancer, dialysis and eye surgery to a wider
population across Berkshire and its borders. The hospital has undergone an extensive
building programme with consolidation of services onto a single site.
The combined bed number for the Trust currently stands at approximately 813. All major
clinical specialities with the exception of Neurosurgery and Cardiothoracic surgery are
carried out by the Trust. The Oncology Department at the Royal Berkshire Hospital has
undergone a rapid expansion in the recent years and is recognised as the Berkshire
Cancer Centre.
Cellular Pathology at the Royal Berkshire Hospital
The Department of Cellular Pathology encompasses Histopathology and Cytopathology.
The Department of Cellular Pathology provides a diagnostic service for the NHS Trust
and the local General Practitioners. The annual workload consists of approximately:
26,500
525
4500
Surgical Histopathology specimens (of which approximately 20% are from
GPs)
Post Mortems (mainly coronial cases)
Non-gynaecological Cytology specimens (including 2,000 fine needle
aspirates)
Histopathology Services
Surgical specimens are received from all major specialties except thoracic surgery and
neurosurgery. In addition to the usual range of material there are regular image guided
biopsies from thoracic, abdominal and pelvic viscera. The department deals with a
substantial amount of new tumour pathology, partly as a consequence of the expansion
of the on-site Berkshire Cancer Centre.
The Royal Berkshire NHS Foundation Trust is a Bowel Screening Centre, and currently
all biopsies and polypectomy specimens generated from the Bowel Screening Clinic are
outsourced and reported elsewhere. However all follow up resection specimens
performed are reported locally.
The department provides an OSNA service (One-step Nucleic Acid Amplification) for
intraoperative detection of lymph node metastasis in breast cancer patients.
Cytopathology Services
The Cervical cytology service is contracted to Ashford and St. Peter’s Hospital and is not
dealt with in the department.
Non-gynaecological cytology specimens include routine urine, sputum and serous fluid
(30%), FNAs (mainly breast) (60%), bronchial, gastric brushings and EBUS samples
(10%).
The Department supports a busy breast diagnostic service. There is currently one
weekly Rapid Diagnostic Breast FNA Clinic at the Royal Berkshire Hospital with input
from the Consultant pathologist staff (in rotation).
Teaching in the Histopathology Training Programme in HETV
Most of the teaching is carried out through participation in the routine workload of
each department with increasing responsibility expected with each year of training. In
addition to this there are formal teaching sessions in-house at each training location
and there are regional Calman sessions in which there is structured, systemic
teaching, which are held on average once a month.
There is opportunity to attend courses outside of the region provided there is
sufficient study leave available.
Duties of Post
The clinical aspects of the programme involve participation in the routine diagnostic
workload of the department in the form of surgical specimen reporting (cut-up,
microscopic examination of slides, use of ancillary techniques including
immunohistochemistry and molecular diagnostics) and participation in MDT
meetings, reporting of non-cervical cytology specimens, and for all in stage B of
training and thereafter if continued as an optional training package, cervical
cytopathology reporting and autopsies. These duties will be carried out under
consultant supervision and in accordance with the local rota.
It is envisaged that the appointee will have 3 month blocks off the clinical rota per
year to accomplish the research component of this post. However, this will be
flexible and depending on the appointee and their proposed project, a variation on
how this research time is distributed throughout the three year post will be
considered. Scheduling of DGH rotations will also be flexible so as to maintain
research continuity and allow for 2 of the 3 year period spent in Oxford.
Academic Programme Director
Dr Clare Verrill (Department of Cellular Pathology, John Radcliffe Hospital, Oxford)
Clinical Programme Directors
Oxford - Dr Eve Fryer (Department of Cellular Pathology, John Radcliffe Hospital,
Oxford)
Head of School of Histopathology and Training Programme Director - Dr Lisa
Browning
Programme contact for further information
Dr Clare Verrill 01865 220150
Clare.Verrill@ouh.nhs.uk
Dr Lisa Browning 01865 222744
Lisa.browning@ouh.nhs.uk
Main Conditions of Service
Appointments to this programme are subject to the Terms and Conditions of Service
(TCS) for Hospital Medical and Dental Staff (England and Wales). In addition
appointments are subject to:
 Applicants having the right to work and be a doctor or dentist in training in the
UK
 Registration with the General Medical Council
 Pre-employment checks carried out by the Trust HR department in line with
the NHS employment check standards, including CRB checks and
occupational health clearance.
The employing Trust’s offer of employment is expected to be on the following
nationally agreed terms:
Hours – The working hours for junior doctors in training are now 48-hours (or 52hours if working on a derogated rota) averaged over 26 weeks (six months). Doctors
in training also have an individual right to opt-out if they choose to do so, but they
cannot opt-out of rest break or leave requirements. However, the contracts for
doctors in training make clear that overall hours must not exceed 56 hours in a
week (New Deal Contract requirements) across all their employments and any
locum work they do.
http://www.nhsemployers.org/your-workforce/need-to-know/european-working-timedirective
Pay – you should be paid monthly at the rates set out in the national terms and
conditions of service for hospital medical and dental staff and doctors in public health
medicine and the community health service (England and Wales), “the TCS”, as
amended from time to time. The payscales are reviewed annually. Current rates of
pay may be viewed at
http://www.nhsemployers.org/your-workforce/pay-and-reward/pay/pay-andconditions-circulars/medical-and-dental-pay-and-conditions-circulars Part time posts
will be paid pro-rata
Pay supplement –depending upon the working pattern and hours of duty you are
contracted to undertake by the employer you should be paid a monthly additional
pay supplement at the rates set out in paragraph 22 of the TCS. The current
payscales may be viewed at
http://www.nhsemployers.org/your-workforce/pay-and-reward/pay/pay-andconditions-circulars/medical-and-dental-pay-and-conditions-circulars
The pay supplement is not reckonable for NHS pension purposes. The pay
supplement will be determined by the employer and should be made clear in their
offer of employment and subject to monitoring.
Pension – you will be entitled to join or continue as a member of the NHS Pension
Scheme, subject to its terms and rules, which may be amended from time to time. If
you leave the programme for out of programme experience you may have a gap in
your
pension
contributions.
More
information
can
be
found
at
http://www.nhsbsa.nhs.uk/pensions
Annual Leave – your entitlement to annual leave will be five or six weeks per annum
depending on your previous service/incremental point, as set out in paragraphs 205206 of the TCS. The TCS may be viewed at
http://www.nhsemployers.org/your-workforce/pay-and-reward/nhs-terms-andconditions/junior-doctors-dentists-gp-registrars/junior-doctors-terms-and-conditionsof-service-and-associated-documents
Sick pay – entitlements are outlined in paragraph 225 of the TCS.
Notice –you will be required to give your employer and entitled to receive from them
notice in accordance with paragraphs 195-196 of the TCS.
Study Leave –the employer is expected to offer study leave in accordance with
paragraphs 250-254 of the TCS. Local policy and procedure will be explained at
induction.
Travel Expenses – the employer is expected to offer travel expenses in accordance
with paragraphs 277-308 of the TCS for journeys incurred in performing your duties.
Local policy and procedure should be explained at induction.
Subsistence expenses – the employer is expected to offer subsistence expenses in
accordance with paragraph 311 of the TCS. Local policy and procedure should be
explained at induction.
Relocation expenses – the employer will have a local policy for relocation expenses
based on paragraphs 314 – 315 of the TCS and national guidance at
http://www.nhsemployers.org/PayAndContracts/MedicalandDentalContracts/JuniorD
octorsDentistsGPReg/Pages/DoctorsInTrainingJuniorDoctorsTermsAndConditions150908.aspx
You are advised to check eligibility and confirm any entitlement with the employer
before incurring any expenditure.
Pre-employment checks – all NHS employers are required to undertake preemployment checks. The employer will confirm their local arrangements, which are
expected to be in line with national guidance at
http://www.nhsemployers.org/your-workforce/recruit/employment-checks/nhsemployment-check-standards
Professional registration – it will be a requirement of employment that you have
professional registration with the GMC/GDC for the duration of your employment.
Though the post is covered by NHS Indemnity, you are strongly advised to register
with the MPS for professional indemnity.
Health and Safety – all employers have a duty to protect their workers from harm.
You should be advised by the employer of local policies and procedures intended to
protect your health and safety and expected to comply with these.
Disciplinary and grievance procedures – the employer will have local policies and
procedures for dealing with any disciplinary concerns or grievances you may have.
They should advise you how to access these, not later than eight weeks after
commencement of employment.
Educational Supervisor – the employer or a nominated deputy (usually the Director
of Medical Education) will confirm your supervisor on commencement.
General information on the LETB’s management of Specialty Training
programmes, including issues such as taking time out of programme and dealing
with concerns or complaints, is available at www.oxforddeanery.nhs.uk and in the
national ‘Gold guide’ to Specialty Training at http://specialtytraining.hee.nhs.uk/.
Please ensure that you inform Health Education Thames Valley of any changes to
your contact details.